When done safely and securely, automated inbound engagement can provide significant benefits for pharmaceutical companies.
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
U.S. President Donald Trump’s threats to slap tariffs on medicines could rattle an industry that has become a cornerstone of ...
West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong dollar and as the medical equipment maker's clients reduce inventory levels, ...
This acquisition marks a significant step in Jubilant Biosys' global strategy, providing a foothold in Europe's expanding ...
20m
Zacks Investment Research on MSNWST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins DownWest Pharmaceutical Services, Inc. WST delivered adjusted earnings per share (EPS) of $1.82 in the fourth quarter of 2024, ...
Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...
U.S. investors and pharmaceutical giants are increasingly looking to China for drug innovation, with nearly 30% of major pharma deals last year involving Chinese companies—up from 0% in 2019.
Kennedy managed to allay the concerns of several key GOP senators over his anti-vaccine activism. Mitch McConnell was the ...
As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.
(WST) on Thursday reported fourth-quarter profit of $130.1 million. The Exton, Pennsylvania-based company said it had net ...
Using money from the opioid settlement funds from big pharmaceutical companies, St. Johns County will partner with EPIC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results